Belldegrun Arie - Insider Non-Derivative Transactions at Allogene Therapeutics, Inc. (ALLO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 16, 2024, Belldegrun Arie's relationship to Allogene Therapeutics, Inc. (ALLO) is Director, and currently has 1,724,137 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ALLO insiders.
Data Source: SEC.
Belldegrun Arie - Insider Non-Derivative Transactions of ALLO Common Stock
Belldegrun Arie - Insider Non-Derivative Transactions at ALLO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 17, 2024 | Acquisition -- (Common Stock) | 344828 | 2.9 | 539867 |
| May 17, 2024 | P -- (Common Stock) | 1724137 | 2.9 | 1724137 |
| Jan 26, 2024 | Acquisition -- (Common Stock) | 211973 | 0 | 1866859 |
| Mar 23, 2023 | Acquisition -- (Common Stock) | 1282976 | 0 | 1654886 |